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Abstract
Background: A consistent line of investigation suggests that autonomic nervous system dysfunction may explain
the multi-system features of fibromyalgia (FM); and that FM is a sympathetically maintained neuropathic pain
syndrome. Dorsal root ganglia (DRG) are key sympathetic-nociceptive short-circuit sites. Sodium channels located in
DRG (particularly Nav1.7) act as molecular gatekeepers for pain detection. Nav1.7 is encoded in gene SCN9A of
chromosome 2q24.3 and is predominantly expressed in the DRG pain-sensing neurons and sympathetic ganglia
neurons. Several SCN9A sodium channelopathies have been recognized as the cause of rare painful dysautonomic
syndromes such as paroxysmal extreme pain disorder and primary erythromelalgia. The aim of this study was to
search for an association between fibromyalgia and several SCN9A sodium channels gene polymorphisms.
Methods: We studied 73 Mexican women suffering from FM and 48 age-matched women who considered
themselves healthy. All participants filled out the Fibromyalgia Impact Questionnaire (FIQ). Genomic DNA from
whole blood containing EDTA was extracted by standard techniques. The following SCN9A single-nucleotide
polymorphisms (SNP) were determined by 5’ exonuclease TaqMan assays: rs4371369; rs4387806; rs4453709;
rs4597545; rs6746030; rs6754031; rs7607967; rs12620053; rs12994338; and rs13017637.
Results: The frequency of the rs6754031 polymorphism was significantly different in both groups (P = 0.036)
mostly due to an absence of the GG genotype in controls. Interestingly; patients with this rs6754031 GG genotype
had higher FIQ scores (median = 80; percentile 25/75 = 69/88) than patients with the GT genotype (median = 63;
percentile 25/75 = 58/73; P = 0.002) and the TT genotype (median = 71; percentile 25/75 = 64/77; P = 0.001).
Conclusion: In this ethnic group; a disabling form of FM is associated to a particular SCN9A sodium channel gene
variant. These preliminary results raise the possibility that some patients with severe FM may have a dorsal root
ganglia sodium channelopathy.
Keywords: Fibromyalgia, SCN9A, Sodium channels, Sympathetic pain, Dorsal root ganglia, Sympathetic nervous sys-
tem, Autonomic nervous system, Neuropathic pain, Sodium channelopathy
Background
The background information leading to the present inves-
tigation has been already published as a hypothesis [1] and
is summarized here: A consistent line of investigation sug-
gests that autonomic nervous system dysfunction may
explain the multi-system features of fibromyalgia (FM);
and that FM is a sympathetically maintained neuropathic
pain syndrome. Trauma and infection are two recognized
FM triggers. In animal models; trauma or infection can
induce phenotypic changes in the dorsal root ganglia
(DRG) leading to a persistent sympathetically-maintained
pain state [1].
DRG are nodules that lie along the spinal column.
They play a key role in pain perception. DRG house the
cell bodies of sensory neurons; the dendrites of which
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internal organs. DRG act also as viral sanctuaries. Under
normal circumstances; DRG have scant sympathetic
innervation. Nevertheless; trauma and/or infection trig-
ger sympathetic sprouting within DRG via nerve growth
factor over-expression. Such aberrant neuroplasticity
enables catecholamines and sympathetic traffic to induce
sensory neuron firing. Sodium channels play a pivotal
role in this hyperexcitability. These mechanisms are the
basis of the sympathetically-maintained pain concept [1].
Sodium channels located in DRG act as molecular gate-
keepers of pain detection at peripheral nociceptors. Nine
sodium channel subunits have been identified (Nav1.1-
Nav1.9); each with a unique central and peripheral ner-
vous system distribution. An isoform (Nav1.7) encoded
in gene SCN9A of chromosome 2q24.3 is predominantly
expressed in the DRG pain-sensing neurons and sympa-
thetic ganglia neurons [2]. Different Nav1.7 mutations
induce electrical hyperactivity of sensory neurons in
DRG and; at the same time; produces hypo-reactivity of
sympathetic ganglia neurons [3-5]. Several sodium “chan-
nelopathies” have been associated to rare painful dysau-
tonomic syndromes such as primary erythromelalgia and
paroxysmal extreme pain disorder (formerly familial rec-
tal pain syndrome). Moreover; a nucleotide polymorph-
ism in the SCN9A gene (rs6746030) was related to pain
perception intensity in individuals with different painful
diseases [6]. This polymorphism makes DRG neurons
hyperexcitable [7].
This information lead us to the present investigation
whose objective was to search for an association
between several SCN9A sodium channels gene poly-
morphisms and fibromyalgia.
Methods
We studied 73 Mexican women suffering from FM
according to the 1990 American College of Rheumatol-
ogy criteria. These patients were referred from different
private rheumatology practices in Mexico. As controls;
we studied 48 Mexican women who considered them-
selves to be healthy and who denied having chronic pain.
Patients and controls were matched by age. Mexicans
have diverse ethnicity. The great majority have European
and Native American background. “Mestizo” is the term
used to name this mixed heritage. All individuals
included in the study were born in Mexico and were cat-
alogued as Mestizo. No further genealogical characteriza-
tion was done. Both patients and controls filled out a
validated Spanish translation of the Fibromyalgia Impact
Questionnaire (FIQ) [8].
This research complies with the Helsinki Declaration.
Informed consent was obtained from all participants;
and the Human Research Committee of the National
Institute of Cardiology of Mexico approved the study.
This group of subjects is the same reported in our pre-
vious genetic studies in FM looking for polymorphisms
of the adrenergic receptor [9] and catecholamine-
degrading enzyme (COMT) [10]. In the present investi-
gation; we were unable to include samples from Spanish
individuals; because there was no more DNA material
available.
Genotyping
Genomic DNA from whole blood containing EDTA was
extracted by standard techniques [11]. Ten different sin-
gle-nucleotide polymorphisms (SNPs) were studied
(rs4371369; rs4387806; rs4453709; rs4597545; rs6746030;
rs6754031; rs7607967; rs12620053; rs12994338; and
rs13017637). SNPs were analyzed by 5’ exonuclease Taq-
Man assay on a 7900HT Fast real-time PCR system
according to manufacturer’s instructions (Applied Biosys-
tems; Foster City; CA). The National Center for Biotech-
nology Information (Bethesda; MD) SNP database was
used to assign SNP numbers.
Statistical analysis
Statistical analysis was carried out with Stata 8.0 software
for Windows (StataCorp; College Station; TX). A chi-
square test was used to evaluate Hardy-Weinberg equili-
brium for each polymorphism. In the exploratory analysis;
numeric data showed a non-normal (non-Gaussian) distri-
bution (P >0 . 0 5b yS h a p i r o - W i l ks t a tistics); therefore;
data were measured as median and interquartile range.
The Kruskal-Wallis test was used to compare visual analog
scale (VAS) scores on the FIQ with SNPs and genotypes.
Proportions of patients and controls per SNP were esti-
mated and compared using chi square or Fisher’se x a c t
tests; as required; and presented as absolute frequencies
and proportions. Statistical significance was set at an alpha
level of less than or equal to 0.05. Pair wise linkage dise-
quilibrium (LD; D’) estimations between polymorphisms
and haplotype reconstruction were performed with Haplo-
view version 3:32 (Broad Institute of Massachusetts Insti-
tute of Technology and Harvard University; Cambridge;
MA).
Results
Table 1 summarizes the baseline characteristics of the
studied individuals and genotype distribution of all
SCN9A SNPs studied. The observed and expected fre-
quencies of the different SNPs were in Hardy-Weinberg
equilibrium. When polymorphisms were analyzed; a dif-
ferent distribution of the rs6754031 SNP was observed in
patients when compared to healthy controls (P = 0.036)
mostly due to an absence of the GG genotype in controls.
Correlation analysis between SNPs and total FIQ score
showed that patients with the rs6754031 GG genotype
had higher total FIQ scores (median = 80; percentile
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(median = 63; percentile 25/75 = 58/73; P = 0.002) or the
TT genotype (median = 71; percentile 25/75 = 64/77;
P = 0.001) (Table 2).
LD analysis among nine SNP markers. showed that six
of them (rs4597545; rs4387806; rs6754031; rs12620053;
rs13017637; rs12994338) had strong LD. One SNP
(rs6746030) was not studied because too few individuals
were determined for this variant. In light of the strong
LD; we analyzed the most frequent haplotypes in
patients and healthy controls to determine whether
some of these haplotypes could be associated with the
risk of developing FM. The distribution of the different
haplotypes was similar in patients and healthy controls
(data not shown).
Discussion
This group of Mexican patients suffering from FM dis-
played different distribution of SCN9A rs6754031 geno-
types when compared to ethnic; age; and gender matched
controls. The difference was due mostly to the absence of
the rs6754031 GG genotype in controls. Additionally; in
this group of FM patients; the rs6754031 GG genotype is
associated with severe disease; as assessed by the FIQ. To
our knowledge there is no prior research linking
rs6754031 with any particular illness. Although no causal-
ity could be derived from the present investigation; these
preliminary results raise the possibility that some patients
with severe FM may have a DRG sodium channelopathy.
We are not aware of previous studies looking at
SCN9A sodium channels gene variation in FM. However;
Reimann et al. studied several SCN9A polymorphisms in
patients with different painful syndromes; including
osteoarthritis; sciatica; amputee phantom pain; spine sur-
gery and pancreatitis. They found a link of rs6746030
with pain intensity. They did not study the SNP
rs6754031 that we found associated to FM severity [6].
On the other hand; in our study; rs6746030 did not dif-
ferentiate FM patients from controls. Evidence emerging
from these two studies suggests that in different painful
conditions; including FM; pain perception may be linked
to dorsal root ganglia/sympathetic ganglia sodium chan-
nels gene variations. There may be different predisposing
polymorphisms for different ethnic groups. In view of the
fact that SCN9A Nav1.7 gene encodes sodium channels
located preferentially in dorsal root ganglia and sympa-
thetic ganglia; our results provide additional evidence to
the concept that FM may be a sympathetically main-
tained neuropathic pain syndrome [12]. Nav1.7 muta-
tions induce electrical hyperactivity of sensory neurons in
DRG; and; at the same time; produce hypo-reactivity of
sympathetic ganglia neurons. This paradoxical behavior
is also seen in FM. Generalized pain coexists with sympa-
thetic hypo-reactivity to different types of stressors [13].
After the submission of this manuscript Faber et al.
published a gain of function SCN9A mutation associated
to idiopathic small fiber neuropathy. This novel finding
points to a broader role of Na(V) 1.7 mutations in painful
neurological disease than previously considered from stu-
dies on rare genetic syndromes [14].
Table 1 Demographic data and comparison of cases and
controls
Cases Controls
Age, mean ± SD years 44 ± 12 43 ± 12
FIQ score (0-100), mean ± SD 68 ± 12 03 ± 03
Genotype n (%) n (%) P
rs 7607967 AA 35 (46) 20 (43) NS
AG 28 (37) 22 (48)
GG 13 (17) 4 (9)
rs 12994338 CC 47 (63) 25 (52) NS
CT 25 (33) 19 (40)
TT 3 (4) 4 (8)
rs 4371369 AA 36 (47) 15 (32) NS
AG 29 (38) 25 (53)
GG 12 (15) 7 (15)
rs 4453709 AA 13 (16) 8 (17) NS
AT 32 (42) 20 (43)
TT 32 (42) 19 (40)
rs 4597545 CC 21 (27) 16 (33) NS
CG 42 (55) 18 (38)
GG 14 (18) 14 (29)
rs 4387806 CC 36 (47) 20 (42) NS
CT 35 (46) 19 (39)
TT 5 (7) 9 (19)
rs 6754031 GG 8 (11) 0 0.036**
GT 24 (33) 15 (31)
TT 41 (56) 33 (69)
rs 12620053 AA 34 (47) 17 (35) NS
AC 27 (38) 21 (44)
CC 11 (15) 10 (21)
rs 13017637 CC 36 (50) 28 (58) NS
CT 25 (34) 18 (38)
TT 11 (15) 2 (4)
rs 6746030 AA 1 (1) 0 NS
AG 12 (17) 6 (13)
GG 57 (82) 40 (87)
Proportions of genotype in each SNP
** Fisher’s exact test
Different numbers of individuals were analyzed for each polymorphism
Table 2 Fibromyalgia Impact Questionnaire score in
patients with rs6754031
Genotype Percentile 25 Median Percentile 75 P value
GG 69.74 80.38 88.74 0.039
GT 58.55 63.29 77.53
TT 64.23 71.25 77.00
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found an association of two catechol-o-methyl transfer-
ase (COMT) enzyme gene polymorphisms with FIQ
subscales. COMT rs6269 was associated with pain and
fatigue; and COMT rs165599 with morning stiffness
and disability [9]. Another study in this same group
looking at adrenergic receptor (AR) gene polymorph-
isms disclosed an association between beta 2 adrener-
gic receptor AC haplotype and the presence of FM. In
addition; patients with AR rs574584 GG genotype pre-
sented the highest FIQ score as compared with patients
with other AR rs574584 genotypes. AR SNP rs574584
was associated with FIQ morning stiffness and with
FIQ tiredness upon awakening [10]. The results of
these studies suggest a complex polygenic genetic pre-
disposition for the development of FM. These three
elements (catecholamines; adrenergic receptors; and
sodium channels) could theoretically interact in the
induction of FM pain.
We recognize limitations in this pilot study. The sample
size is not large enough to withstand multiple comparisons
of common gene polymorphisms; therefore a type II statis-
tical error is possible. Nevertheless; the following two find-
ings favor a real linkage between rs6754031 GG genotype
and Mexican FM patients: 1) rs6754031 polymorphism
was significantly different in both groups mostly due to an
absence of the GG genotype in controls. 2) In the patients
group the same rs6754031 GG genotype was associated to
a severe disease. Studies in other ethnic groups with a lar-
ger sample size are needed to verify or amend these preli-
minary observations.
Another limitation of our study is the lack of rs6754031
functional profiling. Techniques such as patch methods or
functional expression assays are beyond our capabilities.
So; at the present time; the link between SCN9A poly-
morphism and severe FM is just associative. Nevertheless;
our findings raise the possibility that DRG could be an
important element in the pathogenesis of FM; a site in
which physical; emotional; or infective stimuli could be
converted into chronic pain [15]. Genetic functional profil-
ing [3,7,14]; advanced imaging techniques [16] or histology
in the recently described FM animal model [17] could test
this novel proposal
The results of the present investigation may have
potential therapeutic implications. If future investigations
confirm the Nav1.7 sodium channels dysfunction in FM;
then sodium channel blockers may become a therapeutic
option. Preliminary evidence supports this contention.
Lignocaine; a non-specific sodium channel blocker;
appears to reduce FM pain [18]. Duloxetine; another
drug used in FM; blocks Nav1.7 sodium channels in a
state-dependent manner [19]. However; current channel
blockers are weak and non-specific. Selective tetrodo-
toxin-resistant channel blockers are being developed and
may in the future constitute a therapeutic option for FM
pain (1).
Conclusions
Our results show that; in this group of Mexican women;
there is an association of the rs6754031 polymorphism
with the risk of developing FM; as well as with the FIQ
score. This association raises the possibility that some
patients with severe FM may have a DRG sodium
channelopathy.
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